IRSIDA XHIHANI: Open Payments
NPI 1659041127 · CLARKSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 20 payments from 11 companies in 2025. Trend: 2023 $1,192 · 2024 $3,160 · 2025 $678
Long term medical supply or device loan: $333Food & beverage: $325Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $355 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| Eisai Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Aveo Pharmaceuticals, Inc. | 2 | $39 |
| Daiichi Sankyo Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
Products named: KISQALI, KEYTRUDA, Lenvima, FOTIVDA, INJECTAFER, IMBRUVICA, PLUVICTO, Nubeqa.
Industry payments across MI — which companies pay providers there.
